C12N 2506/08
From cells of the nervous system
Official title: from cells of the nervous system
C12N2506/08 (From cells of the nervous system) appears on 102 US grants and 244 published applications in this corpus.
Search patents in C12N- Granted patents
- 102
- Published applications
- 244
- Assignees
- 142
- Inventors
- 493
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 3 |
| 2004 | 1 | 4 |
| 2005 | 2 | 5 |
| 2006 | 1 | 8 |
| 2007 | 1 | 5 |
| 2008 | 0 | 2 |
| 2009 | 1 | 4 |
| 2010 | 2 | 9 |
| 2011 | 3 | 8 |
| 2012 | 4 | 13 |
| 2013 | 3 | 7 |
| 2014 | 3 | 6 |
| 2015 | 5 | 13 |
| 2016 | 6 | 16 |
| 2017 | 11 | 15 |
| 2018 | 7 | 18 |
| 2019 | 7 | 12 |
| 2020 | 11 | 12 |
| 2021 | 8 | 12 |
| 2022 | 3 | 17 |
| 2023 | 6 | 16 |
| 2024 | 6 | 18 |
| 2025 | 4 | 12 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Stem cell-derived Schwann cells19 May 2026US 12,630,801 B2Memorial Sloan Kettering Cancer Center
- Generation of tumor immunity using astrocytes and astrocyte-dendritic cell combinations5 May 2026US 12,618,046 B2
- Application of TGF-B inhibitor in inducing neural stem cells and organoid formation10 Feb 2026US 12,545,892 B2Iregene Therapeutics Ltd
- Differentiation method of neural stem cells manufactured by direct cell conversion into astrocytes3 Feb 2026US 12,540,310 B2Korea University Research and Business Foundation
- Reprogramming method27 Aug 2026US 2026/0250639 A1The Babraham Institute
- Method for differentiating neural crest stem cells comprising axial specification information16 Jul 2026US 2026/0201324 A1Bless Biotherapeutics Inc.
- Triple tissue culture fusion2 Jul 2026US 2026/0185056 A1Imba—Institut FüR Molekulare Biotechnologie GmbH
- Method for trans-differentiating non-neuronal cells into neurons and use thereof26 Mar 2026US 2026/0085284 A1Shanghai Genemagic Biosciences Co., Ltd.
- Methods of making, expanding and purifying midbrain dopaminergic progenitor cells26 Feb 2026US 2026/0055367 A1BrainXell, Inc.
Most cited
By later US patents
- Generation of hematopoietic cells from multipotent neural stem cells78US 6,093,531 ANeurospheres Holdings Ltd. · 2000
- Neuroepithelial stem cells and glial-restricted intermediate precursors21US 6,361,996 B1University of Utah Research Foundation · 2002
- Common neural progenitor for the CNS and PNS20US 6,830,927 B2University of Utah Research Foundation · 2004
- Adipose stromal stem cells for tissue and vascular modification18US 8,067,234 B2Tissue Genesis, Inc. · 2011
- Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof17US 8,067,233 B2Reliance Life Science Pvt. Ltd. · 2011